Categories
Archives
- 2026
- 2025
- 2024
- 2023
Sep
23
UCB Announces U.S. FDA Approvals for BIMZELX® (bimekizumab-bkzx) for the Treatment of Psoriatic Arthritis, Non-radiographic Axial Spondyloarthritis, and Ankylosing Spondylitis
Sep
23
Redefining Immunology Care: Our Pledge to Patients and the Healthcare Community
Sep
09
TK2d Awareness Day: The complexity of this rare, genetic mitochondrial disease and its impact on daily living can no longer be overlooked
